Avacta Life Sciences Limited
  • About
    • About Avacta
    • Group Team
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
  • Diagnostics
  • Investors
  • News
  • Careers
  • Contact
  • About
    • About Avacta
    • Group Team
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
    • Therapeutics
    • preCISIONTM
    • Affimer®
    • Pipeline
    • Partners
    • Clinical trials
    • Team
    • News
  • Diagnostics
    • Diagnostics
    • Our Brands
    • Affimer®
    • Team
    • News
  • Investors
    • Investors
    • CEO Welcome
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Research
  • News
  • Careers
    • Job vacancies
    • About Avacta
    • Benefits of working at Avacta
  • Contact
  • About
    • About Avacta
    • Group Team
    • Scientific Resources
    • Intellectual Property
    • Virtual tour
  • Therapeutics
    • Therapeutics
    • preCISIONTM
    • Affimer®
    • Pipeline
    • Partners
    • Clinical trials
    • Team
    • News
  • Diagnostics
    • Diagnostics
    • Our Brands
    • Affimer®
    • Team
    • News
  • Investors
    • Investors
    • CEO Welcome
    • Key info
    • Corporate Governance
    • Resources
    • Share price
    • RNS News
    • Research
  • News
  • Careers
    • Job vacancies
    • About Avacta
    • Benefits of working at Avacta
  • Contact
Home About Scientific Resources

Scientific Resources

Posters
  • Affimer® proteins: A novel therapeutic platform
  • AVA3996, a novel pre|CISION™ medicine, targeted to the tumor microenvironment via Fibroblast Activation Protein-alpha (FAP-a) mediated cleavage
  • AVA6000, a novel pre|CISION™ medicine, targeted to the tumor microenvironment via FAP mediated cleavage
  • Pharmacokinetic and Biodistribution of Formatted Affimer® Biotherapeutics Targeting PD-L1
  • Half-life Extension Formatting of Human PD-L1 Antagonist Therapeutic Affimers
  • Affimer® reagents facilitate affinity chromatography purification of IgG
  • See more
Published Papers
  • RAS-inhibiting biologics identify and probe druggable pockets including an SII-?3 allosteric site
  • Affimer-enzyme-inhibitor switch sensor for rapid wash-free assays of multimeric proteins
  • Affimers as anti-idiotypic affinity reagents for pharmacokinetic analysis of biotherapeutics
  • Selective Affimers Recognize BCL-2 Family Proteins Through Non-Canonical Structural Motifs
  • See more
Avacta Life Sciences Limited
  • Terms of Use
  • Terms & Conditions
  • Privacy Policy
  • Intellectual Property
  • Returns & cancellations policy
  • Corporate Responsibility
  • Contact Us

Avacta Diagnostics

Unit 20, Ash Way
Thorp Arch Estate
Wetherby
LS23 7FA
+44 (0)1904 21 7070

virtual tour
email

Avacta Therapeutics

Scale Space,  White City
Imperial College Campus
58 Wood Lane
London
W12 7RZ

+44 (0)20 3871 9700

Investor Enquiries

Consilium
Strategic Communications
85 Gresham Street
London
EC2V 7NQ

Email

Twitter | Linkedin

©2023 Avacta Life Sciences Limited. Registered company no. 06605196.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok